U.S., March 28 -- ClinicalTrials.gov registry received information related to the study (NCT07496736) titled 'Post-exposure Influenza Prophylaxis' on March 22.

Brief Summary: The purpose of this study is to compare the efficacy of 5-day versus 10- day oseltamivir prophylactic treatment in patients who had been exposed to influenza.

Study Start Date: Dec. 01, 2025

Study Type: INTERVENTIONAL

Condition: Influenza

Intervention: DRUG: Oseltamivir (Tamiflu)

oseltamivir 5 days

DRUG: Oseltamivir (Tamiflu)

oseltamivir 10 days

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: University Medical Centre Ljubljana

Information provided by (Responsible Party): Dasa Stupica, University Medical Centre Ljubljana

Disclaimer: Curated by HT Syndi...